
Bijal Parikh, MD, PhD
Associate Professor, Pathology & Immunology
Contact
- Email: bparikh@wustl.edu
- Phone: 314-273-7926
Division: Genomic & Molecular Pathology
Titles
Interim Medical Director, Molecular Infectious Disease Laboratory
LGM & GMP Patient Safety and Quality Officer
Director, BJH Molecular Diagnostics Lab
Director, Molecular Genetic Pathology Fellowship
Education
BS: Rutgers University, New Brunswick, NJ (1998)
PhD: Rutgers University, New Brunswick, NJ (2004)
MD: Robert Wood Johnson Medical School-Rutgers University, Piscataway, NJ (2006)
Residency, Clinical Pathology: Washington University, St. Louis, MO (2010)
Fellowship, Molecular Genetic Pathology: Washington University, St. Louis, MO (2018)
Boards
Missouri Medical License
American Board of Pathology in Clinical Pathology, 2011
American Board of Pathology in Molecular Genetic Pathology, 2019
Recognition
Outstanding Research Award in Molecular Pathology/Pharmacogenomics, American Association for Clinical Chemistry Annual Meeting, 2009
Paul E. Strandjord Young Investigator Award, Academy of Clinical Laboratory Physicians and Scientists Annual Meeting, 2009, 2010
Chair’s Special Recognition Award, COVID Clinical Hero, Washington University Department of Pathology and Immunology, 2020
Outstanding Achievements in Quality Improvement Award, Washington University Department of Pathology and Immunology, 2020
Faculty Educator of the Year, Clinical Pathology, 2021-2022
Research Interests
My clinical research centers on aspects of laboratory testing involving viral, immunologic, and molecular diagnostics, with a specific focus on the implementation of next-generation sequencing approaches. My translational research focus is the development of novel molecular diagnostics approaches for infectious disease testing.
Selected Publications
Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations
Publication
The impact of FDA-cleared molecular solutions for BK polyomavirus quantitation
Publication
Modified Rules for Classification of Variants Associated With Disorders of Somatic Mosaicism
Publication
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years – VISION and IVY Networks, September 2024-January 2025
Publication
Assistant

IOH Room 5800